Actinium Pharmaceuticals, Inc. (Delaware) financial statements, including revenue, expenses, profit, and loss
The total revenue of ATNM for the last quarter is 0.00 USD, and it's 100.00% lower compared to the previous quarter. The net income of Q1 24 is -8.67 M USD.